HIV Prevention Trials Network
33
0
2
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 33 trials
100.0%
+13.5% vs industry average
18%
6 trials in Phase 3/4
36%
10 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (33)
Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy
Role: lead
INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit
Role: lead
Getting to Zero Among HHI MSM in the American South
Role: lead
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study
Role: collaborator
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103)
Role: collaborator
Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
Role: lead
Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19
Role: collaborator
Pre-Exposure Prophylaxis for Transgender Women in the US and South America
Role: lead
Improving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi
Role: lead
Testing a Barbershop-based HIV Prevention Initiative Among Men
Role: lead
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
Role: collaborator
Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
Role: lead
HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)
Role: lead
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study
Role: collaborator
Integrated Treatment and Prevention for People Who Inject Drugs
Role: lead
Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies
Role: lead
Feasibility of HIV Prevention Cohort Studies Among Men Who Have Sex With Men in Sub-Saharan Africa
Role: lead
The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Role: lead
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Role: lead
A Comparison of Different Community Models of ART Delivery Amongst Stable HIV+ Patients in Two Urban Settings in Zambia
Role: lead